Avid Bioservices Inc (CDMO)

[4OurRetirement]

I Think ESMO PR Worth Reading Again, Especially...

the following quote which to me says that the biomarker results are so good PPHM feels obligated to stockholders to rapidly file for a new patent before the ESMO statsig presentation:

"...Presented data will include a biomarker in the SUNRISE trial that correlated with a statistically significant improvement in overall survival for patients treated with bavituximab in combination with docetaxel compared to patients treated with docetaxel alone. Peregrine will file a new patent application directed to the use of the biomarker prior to the presentation of results at the ESMO..."

Glta StockHOLDERS!